- Protein Name
- Serine/threonine-protein kinase PLK4
- Gene Name
- PLK4
- Organism
-
Homo sapiens
- Function
- Serine/threonine-protein kinase that plays a central role in centriole duplication. Able to trigger procentriole formation on the surface of the parental centriole cylinder, leading to the recruitment of centriole biogenesis proteins such as SASS6, CENPJ/CPAP, CCP110, CEP135 and gamma-tubulin. When overexpressed, it is able to induce centrosome amplification through the simultaneous generation of multiple procentrioles adjoining each parental centriole during S phase. Phosphorylates 'Ser-151' of FBXW5 during the G1/S transition, leading to inhibit FBXW5 ability to ubiquitinate SASS6. Its central role in centriole replication suggests a possible role in tumorigenesis, centrosome aberrations being frequently observed in tumors. Also involved in deuterosome-mediated centriole amplification in multiciliated that can generate more than 100 centrioles. Also involved in trophoblast differentiation by phosphorylating HAND1, leading to disrupt the interaction between HAND1 and MDFIC and activate HAND1. Phosphorylates CDC25C and CHEK2. Required for the recruitment of STIL to the centriole and for STIL-mediated centriole amplification (PubMed:22020124).
Site |
Maximum Consensus Site Population |
Minimum Consensus Site Population |
Median Consensus Site Population |
MPP |
29 |
5 |
26.0 |
DFG |
25 |
7 |
16.0 |
PIF |
23 |
12 |
16.0 |
EDI |
7 |
7 |
7.0 |
MT3 |
15 |
3 |
9.5 |
AAS |
18 |
4 |
11.5 |
CMP |
16 |
7 |
15.0 |
ATP |
27 |
9 |
18.0 |
PDB ID |
Maximum Consensus Site Population |
MPP site |
DFG site |
PIF site |
DRS site |
DEF site |
EDI site |
MT3 site |
AAS site |
LBP site |
CMP site |
PDIG site |
ATP site |
PMP site |
Total Druggable Structures per Site |
3 |
1 |
1 |
0 |
0 |
0 |
0 |
1 |
0 |
1 |
0 |
3 |
0 |
4JXF
|
26 |
0 |
0 |
0 |
0 |
0 |
15 |
12 |
0 |
15 |
0 |
27 |
0 |
3COK
|
29 |
7 |
23 |
0 |
0 |
0 |
10 |
12 |
0 |
15 |
0 |
18 |
0 |
AFO00444
|
0 |
25 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
16 |
0 |
0 |
0 |
4YUR
|
17 |
0 |
12 |
0 |
0 |
7 |
11 |
18 |
0 |
7 |
0 |
18 |
0 |